This webinar will explore the evolving landscape of oncogenetics with a focus on genetic testing and its role in cancer risk assessment, prevention, and personalized care in gynecologic oncology. Experts will discuss the latest advances in genetic screening, including the clinical application of BRCA and Lynch syndrome testing, as well as the emergence of new preventive testing kits now available on the market. A special emphasis will be placed on the gynecologic implications of Lynch syndrome, particularly the elevated risks for endometrial and ovarian cancers and the strategies for risk-reducing management. The program will also delve into recent findings from genome-wide association studies (GWAS) that shed light on genetic variation in cervical preinvasive and invasive disease, expanding our understanding of inherited susceptibility beyond traditional markers. This session will provide clinicians, genetic counselors, and researchers with valuable insights into how genetic information can inform screening decisions, guide preventive strategies, and shape the future of personalized cancer care.